SXTC stock Statistics — China SXT Pharmaceuticals, Inc. filings, insiders & smart money

Beta: Sign in
Shares outstandingAs of 2026-03-31 · filed common shares: 958.07K
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 1.95%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 56.20%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 57.10%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Avg volume (3 months)

Gross marginFY Mar 26: 21.85%
Operating marginFY Mar 26: -625.89%
Net margin: —
EBITDA marginFY Mar 26: -619.42%
Return on equityNet income (FY Mar 26) ÷ average shareholders equity: -27.49%
Return on assetsNet income (FY Mar 26) ÷ average total assets: -22.00%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Mar 26

-9.13

EPS (fwd)

Cash & equivalentsas of Mar 26: $28.17M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Mar 26: $644.39K
Debt / equityas of Mar 26: 2.17%
Current ratioas of Mar 26: 7.93
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Mar 26: 6.69
Operating cash flowFY Mar 26: -$4.01M
Free cash flowUnadjusted FCF = CFO − capex · FY Mar 26: -$4.01M
TTM revenue / diluted shareDiluted, FY Mar 26: 1.67